Intravenous administration of allogeneic Wharton jelly-derived mesenchymal stem cells for treatment of dogs with congestive heart failure secondary to myxomatous mitral valve disease.
V. Yang, Dawn M. Meola, Airiel M. Davis, Bruce Barton, A. Hoffman
American Journal of Veterinary Research